Harrow Health

-$0.04 (-0.48%) As of 7:03 PM UTC today

Why Robinhood?

You can buy or sell Harrow Health and other stocks, options, and ETFs commission-free!

About HROW

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments.

CEO

Mark L. Baum

Employees

125

Headquarters

Nashville, Tennessee

Founded

2006

HROW Key Statistics

Market Cap

240.61M

Price-Earnings Ratio

23.16

Dividend Yield

—

Average Volume

136.32K

High Today

$8.40

Low Today

$8.34

Open Price

$8.37

Volume

176.19K

52 Week High

$11.24

52 Week Low

$4.65

HROW News

BenzingaJun 17

Looking Into Harrow Health's Return On Capital Employed

Harrow Health (NASDAQ:HROW) posted a 7.77% decrease in earnings from Q4. Sales, however, increased by 5.81% over the previous quarter to $15.44 million. Despite

HROW Earnings

-$0.50

-$0.23

$0.05

$0.32

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 9, After Hours